Hib-diphtheria vaccine

Drug Profile

Hib-diphtheria vaccine

Alternative Names: PRP-T/diphtheria vaccine

Latest Information Update: 15 Aug 2002

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Goteborg University; National Public Health Institute (Finland)
  • Class Haemophilus vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Diphtheria; Haemophilus infections

Most Recent Events

  • 02 Dec 1994 Investigation in Diphtheria in Finland (SC)
  • 02 Dec 1994 Investigation in Diphtheria in Sweden (SC)
  • 02 Dec 1994 Investigation in Haemophilus infections in Finland (SC)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top